Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Afroz Hai

Clinical Cardiac Electrophysiology Hoffman Estates, IL Medical Doctor

NPI 1427208099 CMS profile 717505

2359 Hassell Rd, Ste 100, Hoffman Estates, IL 60169

Open in the dashboard

General payments

$4,078

122 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,646 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Afroz Hai of Hoffman Estates, IL is reported in the CMS Open Payments database as having received $4,078 across 122 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,646 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 19th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,003 48
2024 General $1,056 26
2023 General $814 21
2022 General $500 8
2021 General $338 8
2020 General $118 1
2019 General $248 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Afroz Hai
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Afroz Hai were reported at $1,003. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Afroz Hai Clinical Cardiac Electrophysiology median Middle half National median
2019 $248 $2,361 $585–$8,260 $163
2020 $118 $993 $247–$4,351 $114
2021 $338 $1,185 $326–$4,739 $132
2022 $500 $2,073 $554–$6,789 $149
2023 $814 $2,568 $759–$8,159 $160
2024 $1,056 $2,557 $703–$7,403 $164
2025 $1,003 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $1,604 20 payments
  2. Boston Scientific Corporation $394 12 payments
  3. Novartis Pharmaceuticals Corporation $380 22 payments
  4. Medtronic Vascular, Inc. $215 8 payments
  5. Esperion Therapeutics, Inc. $178 3 payments
  6. AstraZeneca Pharmaceuticals LP $175 7 payments
  7. Boehringer Ingelheim Pharmaceuticals, Inc. $153 6 payments
  8. Janssen Pharmaceuticals, Inc $147 6 payments
  9. E.R. Squibb & Sons, L.L.C. $129 7 payments
  10. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $129 11 payments
  11. Other $574 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,078 122 payments
Products named General payments · program years 2019–2025
  1. LEQVIO $380 22 payments
  2. ENSITE PRECISION $341 2 payments
  3. GALLANT Cardiac Rhythm Management $285 2 payments
  4. JOT DX $269 3 payments
  5. XARELTO $244 7 payments
  6. GALLANT Structural Heart $232 3 payments
  7. WATCHMAN Access System $207 8 payments
  8. NEXLETOL $178 3 payments
  9. WATCHMAN $149 3 payments
  10. LifeVest $129 11 payments
  11. Other $1,797 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 21 drugs

Part D claims

1,476

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$241,993

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

19.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 202 $191,302
Xarelto Rivaroxaban Brand 34 $39,173
Metoprolol Succinate Generic 277 $3,667
Amiodarone Hcl Generic 109 $1,995
Metoprolol Tartrate Generic 133 $736
Potassium Chloride Generic 19 $692
Atorvastatin Calcium Generic 52 $615
Hydralazine Hcl Generic 43 $411
Clopidogrel Clopidogrel Bisulfate Brand 32 $411
Furosemide Generic 115 $408

The 10 drugs with the highest cost, of 21 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 79 billing codes

Paid by Medicare

$275,038

Medicare's payments for the services billed

Medicare patients

621

Average age 78

Services billed

3,192

280 women, 341 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 49%
Ischemic heart disease 47%
Arthritis 46%
Heart failure 39%
Diabetes 38%
Chronic kidney disease 38%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 8 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
LEQVIO
  • Novartis Pharmaceuticals Corporation $129
$129 — —
NEXLETOL
  • Esperion Therapeutics, Inc. $123
$123 — —
XARELTO
  • Janssen Pharmaceuticals, Inc $86
$86 34 —
ENTRESTO
  • Novartis Pharmaceuticals Corporation $33
$33 — —
CAMZYOS
  • E.R. Squibb & Sons, L.L.C. $30
$30 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 8 in the dashboard with a free account

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record